Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1994 Sep 1;302(Pt 2):497–502. doi: 10.1042/bj3020497

Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies.

M E Veronese 1, W Burgess 1, X Zhu 1, M E McManus 1
PMCID: PMC1137255  PMID: 8093002

Abstract

The present paper describes the functional characterization of two human aryl sulphotransferase (HAST) cDNAs, HAST1 and HAST3, previously isolated by us from liver and brain, respectively [Zhu, Veronese, Sansom, and McManus (1993) Biochem. Biophys. Res. Commun. 192, 671-676; Zhu, Veronese, Bernard, Sansom and McManus (1993) Biochem. Biophys. Res. Commun. 195, 120-127]. These appear to encode the two major forms of phenol sulphotransferase (PST) characterized in a number of human tissue cytosols, these being the phenolsulphating (P-PST) and monoamine-sulphating (M-PST) forms of phenol sulphotransferase. HAST1 and HAST3 cDNAs were functionally expressed in COS-7 cells and kinetically characterized using the model substrates for P-PST and M-PST, p-nitrophenol and dopamine (3,4-dihydroxyphenethylamine) respectively. COS-expressed HAST1 was shown to be enzymatically active in sulphating p-nitrophenol with high affinity (Km 0.6 microM), whereas dopamine was the preferred substrate for HAST3 (Km 9.7 microM). HAST1 could also sulphate dopamine, as could HAST3 sulphate p-nitrophenol, but the Km for these reactions were at least two orders of magnitude greater than for the preferred substrates. COS-expressed HAST1 and HAST3 displayed inhibition profiles with the ST inhibitor 2,6-dichloro-4-nitrophenol (DCNP), identical with human liver cytosolic P-PST and M-PST activities respectively. Thermal-stability studies with the expressed enzymes showed that HAST1 was considerably more thermostable (TS) than HAST3, which is consistent with P-PST being termed the TS PST and M-PST being termed the thermolabile (TL) PST. Western immunoblot analyses of the expressed PST proteins using an antibody generated to a bacterially expressed rat liver aryl/phenol ST showed that HAST1 and HAST3 migrated as single proteins with different electrophoretic mobilities (32 versus 34 kDa). This is consistent with the differences in electrophoretic mobilities observed for P-PST and M-PST in a variety of tissues reported by other workers. This report on the functional characterization of P-PST and M-PST cDNAs provides important information on the structural as well as functional relationships of human PSTs, which sulphate a vast array of exogenous and endogenous compounds.

Full text

PDF
499

Images in this article

500Figure 5
on p.500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell N. R., Van Loon J. A., Weinshilboum R. M. Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochem Pharmacol. 1987 May 1;36(9):1435–1446. doi: 10.1016/0006-2952(87)90108-0. [DOI] [PubMed] [Google Scholar]
  2. Comer K. A., Falany J. L., Falany C. N. Cloning and expression of human liver dehydroepiandrosterone sulphotransferase. Biochem J. 1993 Jan 1;289(Pt 1):233–240. doi: 10.1042/bj2890233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cruickshank D., Sansom L. N., Veronese M. E., Mojarrabi B., McManus M. E., Zhu X. cDNA expression studies of rat liver aryl sulphotransferase. Biochem Biophys Res Commun. 1993 Feb 26;191(1):295–301. doi: 10.1006/bbrc.1993.1216. [DOI] [PubMed] [Google Scholar]
  4. Falany C. N. Molecular enzymology of human liver cytosolic sulfotransferases. Trends Pharmacol Sci. 1991 Jul;12(7):255–259. doi: 10.1016/0165-6147(91)90566-b. [DOI] [PubMed] [Google Scholar]
  5. Falany C. N., Vazquez M. E., Heroux J. A., Roth J. A. Purification and characterization of human liver phenol-sulfating phenol sulfotransferase. Arch Biochem Biophys. 1990 May 1;278(2):312–318. doi: 10.1016/0003-9861(90)90265-z. [DOI] [PubMed] [Google Scholar]
  6. Foldes A., Meek J. L. Rat brain phenolsulfotransferase: partial purification and some properties. Biochim Biophys Acta. 1973 Dec 19;327(2):365–374. doi: 10.1016/0005-2744(73)90419-1. [DOI] [PubMed] [Google Scholar]
  7. Heroux J. A., Falany C. N., Roth J. A. Immunological characterization of human phenol sulfotransferase. Mol Pharmacol. 1989 Jul;36(1):29–33. [PubMed] [Google Scholar]
  8. McManus M. E., Hall P. D., Stupans I., Brennan J., Burgess W., Robson R., Birkett D. J. Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver. Mol Pharmacol. 1987 Aug;32(1):189–194. [PubMed] [Google Scholar]
  9. Otterness D. M., Wieben E. D., Wood T. C., Watson W. G., Madden B. J., McCormick D. J., Weinshilboum R. M. Human liver dehydroepiandrosterone sulfotransferase: molecular cloning and expression of cDNA. Mol Pharmacol. 1992 May;41(5):865–872. [PubMed] [Google Scholar]
  10. Reiter C., Mwaluko G., Dunnette J., Van Loon J., Weinshilboum R. Thermolabile and thermostable human platelet phenol sulfotransferase. Substrate specificity and physical separation. Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(2):140–147. doi: 10.1007/BF00497020. [DOI] [PubMed] [Google Scholar]
  11. Sundaram R. S., Szumlanski C., Otterness D., van Loon J. A., Weinshilboum R. M. Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form. Drug Metab Dispos. 1989 May-Jun;17(3):255–264. [PubMed] [Google Scholar]
  12. Weinshilboum R. Sulfotransferase pharmacogenetics. Pharmacol Ther. 1990;45(1):93–107. doi: 10.1016/0163-7258(90)90010-y. [DOI] [PubMed] [Google Scholar]
  13. Whittemore R. M., Pearce L. B., Roth J. A. Purification and kinetic characterization of a dopamine-sulfating form of phenol sulfotransferase from human brain. Biochemistry. 1985 May 7;24(10):2477–2482. doi: 10.1021/bi00331a013. [DOI] [PubMed] [Google Scholar]
  14. Whittemore R. M., Pearce L. B., Roth J. A. Purification and kinetic characterization of a phenol-sulfating form of phenol sulfotransferase from human brain. Arch Biochem Biophys. 1986 Sep;249(2):464–471. doi: 10.1016/0003-9861(86)90023-8. [DOI] [PubMed] [Google Scholar]
  15. Wilborn T. W., Comer K. A., Dooley T. P., Reardon I. M., Heinrikson R. L., Falany C. N. Sequence analysis and expression of the cDNA for the phenol-sulfating form of human liver phenol sulfotransferase. Mol Pharmacol. 1993 Jan;43(1):70–77. [PubMed] [Google Scholar]
  16. Young W. F., Jr, Okazaki H., Laws E. R., Jr, Weinshilboum R. M. Human brain phenol sulfotransferase: biochemical properties and regional localization. J Neurochem. 1984 Sep;43(3):706–715. doi: 10.1111/j.1471-4159.1984.tb12790.x. [DOI] [PubMed] [Google Scholar]
  17. Zhu X., Veronese M. E., Bernard C. C., Sansom L. N., McManus M. E. Identification of two human brain aryl sulfotransferase cDNAs. Biochem Biophys Res Commun. 1993 Aug 31;195(1):120–127. doi: 10.1006/bbrc.1993.2018. [DOI] [PubMed] [Google Scholar]
  18. Zhu X., Veronese M. E., Sansom L. N., McManus M. E. Molecular characterisation of a human aryl sulfotransferase cDNA. Biochem Biophys Res Commun. 1993 Apr 30;192(2):671–676. doi: 10.1006/bbrc.1993.1467. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES